Multicenter-based large studies with detailed and frequent staging evaluation data, which enables multifactorial analysis, are recommended to improve the present understanding of the role of α-SMA-expressing fibroblasts for predicting poor survival in HCC. Here, ACTA1 is linked to hepatocellular carcinoma.